1 most recent filing and news item mentioning WVE. Updated every 60 seconds.
EarningsJul 30, 2026Neutral
Wave reported Q2 financial results with $490.6M in cash as of June 30, 2026, noting dosing underway in its Phase 2a obesity trial and data supporting a potential accelerated approval for WVE-006.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.